Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer. - Test2 - elhamkhani - TriplyDB

Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer.

Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer.

http://www.wikidata.org/entity/Q33956668

about

miRNA Alterations Modify Kinase Activation In The IGF-1 Pathway And Correlate With Colorectal Cancer Stage And Progression In Patients Novel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitors Genetic polymorphisms of mTOR and cancer risk: a systematic review and updated meta-analysis Inhibitory effect and mechanism of exogenous mammalian sterile 20-like kinase 1 on the growth of human colorectal cancer Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma.Akt and phospholipase Cγ are involved in the regulation of growth and migration of MDA-MB-468 breast cancer and SW480 colon cancer cells when cultured with diabetogenic levels of glucose and insulin.Synergistic effect of a combination of nanoparticulate Fe3O4 and gambogic acid on phosphatidylinositol 3-kinase/Akt/Bad pathway of LOVO cells.Cytosolic malic enzyme 1 (ME1) mediates high fat diet-induced adiposity, endocrine profile, and gastrointestinal tract proliferation-associated biomarkers in male mice.Phosphatidylinositol 3-kinase CB association with preoperative radiotherapy response in rectal adenocarcinoma The effect of tou nong san on transplanted tumor growth in nude mice.Inositol hexaphosphate suppresses growth and induces apoptosis in HT-29 colorectal cancer cells in culture: PI3K/Akt pathway as a potential target.Tandutinib inhibits the Akt/mTOR signaling pathway to inhibit colon cancer growth.ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/β-Catenin, Notch and PI3K/Akt Signaling Pathways.Expression and clinical significances of Beclin1, LC3 and mTOR in colorectal cancer.PTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational study Rapamycin synergizes with low-dose oxaliplatin in the HCT116 colon cancer cell line by inducing enhanced apoptosis Microsatellite instability & survival in patients with stage II/III colorectal carcinoma.TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium.TDRG1 functions in testicular seminoma are dependent on the PI3K/Akt/mTOR signaling pathway Novel small interfering RNA cotargeting strategy as treatment for colorectal cancer Mesenchymal stem cells promote colorectal cancer progression through AMPK/mTOR-mediated NF-κB activation.Colorectal cancer carcinogenesis: a review of mechanisms Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells Cell survival and metastasis regulation by Akt signaling in colorectal cancer Hsa-miR-137, hsa-miR-520e and hsa-miR-590-3p perform crucial roles in Lynch syndrome.The PI3K-AKT-mTOR pathway activates recovery from general anesthesia Polymorphisms in MicroRNA Binding Sites Predict Colorectal Cancer Survival.Targeting mTOR network in colorectal cancer therapy Elevation of n-3/n-6 PUFAs ratio suppresses mTORC1 and prevents colorectal carcinogenesis associated with APC mutation.SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling.Translation initiation in colorectal cancer.Multimodal treatment strategies for locally advanced rectal cancer.Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers.The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis.Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress.Complex interactions between the components of the PI3K/AKT/mTOR pathway, and with components of MAPK, JAK/STAT and Notch-1 pathways, indicate their involvement in meningioma development.Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer.The role of c2orf68 and PI3K/Akt/mTOR pathway in human colorectal cancer.Activation of the PI3K/Akt/mTOR/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells.Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.

P2860

Q28392422-5197A48F-E71C-4980-9776-79BD4174E9D0 Q28546685-88A6A487-B0D9-48DB-83F1-77AF6B81FB6D Q29248629-CD460F1E-F0A1-4913-9E14-A538AF60D84F Q32178067-BA6F7343-E240-4C30-957C-54A84F5723FA Q34105105-3EB76684-6B2E-40DB-A259-77BE921C537C Q34255016-C8D794B6-BF82-42C3-90E7-8631ADD1F9C2 Q34377965-2C09175D-3FAC-4BEA-BB51-D79591F894F3 Q34441941-6034147D-8487-4B6B-B34A-A2F3D4EB36FC Q34552147-5C07F570-E2FC-4939-B863-D7171199C941 Q35144141-630097C6-0407-4A99-A378-3CD9B956F7B6 Q35405450-EB0A860D-3D80-4679-8B2E-245A8FEDD322 Q35565564-92B56990-AB2C-482D-A49E-6532096BA8CD Q35581875-490BAF21-0EF1-4FB8-A6E5-AEC41BB81F0E Q35741059-BE0C9D57-6EAA-4781-8945-2B5EB9A787C5 Q36050773-39AFA9F2-52DC-44A3-BB41-41F3B136B8CE Q36121278-F87ABB71-59F9-4F79-BE3C-7D088CB90315 Q36164861-C02C4B5B-22C2-49CD-A3A0-DB2FCD14871F Q36347242-B097C083-BDF9-4CFE-9F1A-9764DD7707A4 Q36498943-E3087CD0-4683-49DE-BFB3-49219C1E8E5E Q36564058-0F05555E-C563-4A11-9C41-2B38DF01B4F0 Q36596264-C0FF0CAD-7F41-45CA-87CA-E616A1647AC0 Q36849645-BFED263B-ED0A-4F31-8956-9E7CE78C472E Q36927955-6FE47EF3-7D64-4292-BBF7-4BD339CBAFA3 Q36938826-8A8FDFAE-10FA-435A-9195-0D45090570F2 Q37206009-A3E2EFA0-09DC-4683-B3EB-C22C12ABB050 Q37520114-649147E7-8B6F-495E-9B76-6B932C43852A Q37612867-0FEEC54E-38FC-415B-BF70-F4093475DD5E Q37708005-3E404A54-FF2E-4717-8CAB-9768AA80A0DF Q37718315-138B01C9-97C7-4193-872B-B48FEB0B61F1 Q37746213-71A869C9-14DC-401D-A08D-D05D62AA26EF Q37993753-9A69303F-0F44-49F1-A4DA-8231AFFFA2C9 Q38002470-DC03C079-1712-492B-8271-EC314767379A Q38802590-6B0C5B5E-F867-4C83-90A5-73CAE106FAAB Q38902937-FF73BA90-C63A-47A7-B8A4-7F0A30E963BA Q38946538-5398D5C6-ED5D-4D7B-8997-3F910C3A6B99 Q38963912-2FD0E9D2-4A6E-4A86-A518-7BBB648A7390 Q38965991-D51B0A5B-F13F-4208-A0FB-62CC12A44DB9 Q38975478-B8424F59-D044-4288-B415-653A99B27996 Q38983986-FD6DF273-40EC-44C3-8ADE-8A80BB7E5C83 Q39129195-B32C0C49-2F60-47DF-894C-117F51BC87DF

P2860

Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer.

http://www.wikidata.org/entity/Q33956668

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Novel expression patterns of P ...... mponents in colorectal cancer.

@ast

Novel expression patterns of P ...... mponents in colorectal cancer.

@en

type

label

Novel expression patterns of P ...... mponents in colorectal cancer.

@ast

Novel expression patterns of P ...... mponents in colorectal cancer.

@en

prefLabel

Novel expression patterns of P ...... mponents in colorectal cancer.

@ast

Novel expression patterns of P ...... mponents in colorectal cancer.

@en

P1433

Q33956668-9640E36A-2B0D-4C1C-B9B7-3F635FE6BF5D

P1476

Q33956668-76D82DB9-37EE-4238-A3B9-09DD71B11AE8

P2093

Q33956668-1C00C062-DF6F-446B-8D4C-B6D296BBE1F3

Q33956668-368BF5CE-5431-47E0-9A23-24063A01F8C5

Q33956668-41493AAF-0D3F-4F02-9497-D52C33BD2665

Q33956668-44C47B7F-AFC1-4432-984D-FAA72E4B2054

Q33956668-76C07331-70FE-4A88-8B68-E7529FDD338D

Q33956668-C169E37A-E608-4CF0-A344-74E689061C01

Q33956668-ED41F148-E06A-4610-8474-9DEFDB335CAE

P2860

Q33956668-105F7DEB-299D-4121-8870-D322800E23BC

Q33956668-14AFE79C-C23C-40FA-8351-0C59D88FF969

Q33956668-19D1D906-1D01-4CE2-83E5-D0A2F13B3495

Q33956668-1D037B4E-8CF4-4B62-A4FD-B32177E3D5D1

Q33956668-1FF46845-ACCB-4AD7-8268-22EEDD48FEED

Q33956668-20D63851-D660-4BCF-8184-3768FD8FDDFD

Q33956668-2676801F-76F9-4B1E-9976-382D89047454

Q33956668-2A8A2BAD-F8D3-4A5C-A0C3-CD01FCF4F813

Q33956668-2CA9D693-40D3-4AAE-8019-BBBD5C76672B

Q33956668-2D9A94D8-C867-47F7-A1E1-4599C2EFD4B6

P304

Q33956668-5F2FEA9F-EECA-4EA0-9ED9-BA405A8E3264

P31

Q33956668-BADAC68A-397C-42E0-99CF-343AB1F8E31F

P356

Q33956668-6E679505-C740-45B6-8DED-E8E07AD0BE9D

P433

Q33956668-D3768AA2-4495-4DAB-B569-2845598704BD

P478

Q33956668-23F7789F-CFCE-4135-8DEA-D91531EE16A6

P50

Q33956668-434A5A4D-3D31-4C88-B4FA-0D9E20AB6D05

P577

Q33956668-0290C30B-D347-4CD1-B351-5CF5FFD98889

P5875

Q33956668-ABD7B257-F9B0-4105-9135-04EAFF4F4283

P698

Q33956668-D573612E-0B5E-47BC-9EA8-F2DBC16E5CED

P921

Q33956668-FF215FA0-B1F3-4A35-876B-E746BD8CB6A5

P932

Q33956668-E7B67BC2-617D-4DB7-A726-42DEEEE88A35

P356

J.JAMCOLLSURG.2009.12.008

P1433

Journal of the American College of Surgeons

P1476

Novel expression patterns of P ...... omponents in colorectal cancer

@en

P2093

B Mark Evers

http://www.w3.org/2001/XMLSchema#string

Bill A Rampy

http://www.w3.org/2001/XMLSchema#string

Heidi L Weiss

http://www.w3.org/2001/XMLSchema#string

Hung Q Doan

http://www.w3.org/2001/XMLSchema#string

Pat Gulhati

http://www.w3.org/2001/XMLSchema#string

Sara M Johnson

http://www.w3.org/2001/XMLSchema#string

Yimei Han

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice

Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

A genetic model for colorectal tumorigenesis

The phosphoinositide 3-kinase pathway

Defining the role of mTOR in cancer

Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase

Cancer statistics, 2009

Ras, PI(3)K and mTOR signalling controls tumour cell growth

Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer

P304

767-76, 776-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JAMCOLLSURG.2009.12.008

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

210

http://www.w3.org/2001/XMLSchema#string

P50

Piotr G Rychahou

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43345288

http://www.w3.org/2001/XMLSchema#string

P698

20421047

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

2895913

http://www.w3.org/2001/XMLSchema#string